CureVac N.V. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 15.20M19.28M58.27M117.82M68.79M57.84M571.89M
Cost of Revenue 20.96M30.97M16.90M272.49M187.72M133.81M113.09M
Gross Profit -5.76M-11.70M41.37M-154.67M-118.93M-75.97M458.80M
Operating items
Research & Development 49.29M47.86M135.69M933.37M63.82M124.51M163.53M
Selling, General & Administrative 29.87M54.20M63.85M114.86M106.29M98.73M74.47M
Other Operating Expenses -231.46M-388.76M
Operating Expenses 79.16M-129.40M-189.22M1048.23M170.10M223.24M238.00M
Operating Income -86.03M-110.13M-130.93M-471.62M-254.51M-295.03M189.87M
EBIT -86.03M-110.13M-130.93M-471.62M-254.51M-295.03M189.87M
Non-operating items
Interest & Investment Income 2.32M0.92M2.47M11.56M4.09M18.00M14.99M
Net income details
EBT -84.03M-110.83M-154.82M-471.89M-254.20M-279.71M203.97M
Tax Provisions 0.13M-0.28M-0.87M-0.89M-0.13M0.21M30.66M
Profit After Tax -84.16M-110.55M-153.95M-470.99M-254.07M-279.92M173.31M
Income from Continuing Operations -84.16M-110.55M-153.95M-470.99M-254.07M-279.92M173.31M
Consolidated Net Income -84.16M-110.55M-153.95M-470.99M-254.07M-279.92M173.31M
Income towards Parent Company -84.16M-110.55M-153.95M-470.99M-254.07M-279.92M173.31M
Net Income towards Common Stockholders -84.16M-110.55M-153.95M-470.99M-254.07M-279.92M173.31M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 176.46M186.16M187.05M190.28M223.92M224.34M
EBITDA -86.03M-110.13M-130.93M-471.62M-254.51M-295.03M189.87M
Tax Rate 0.25%0.56%0.19%0.05%15.03%